Oral delivery of peptides: opportunities and issues for translation

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):193-195. doi: 10.1016/j.addr.2016.10.005.

Authors

David J Brayden¹, Maria-Jose Alonso²

Affiliations

¹ UCD School of Veterinary Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: david.brayden@ucd.ie.
² Dept. Of Pharmacy and Pharmaceutical Technology, CIMUS Research Institute, University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.

PMID: 27865345
DOI: 10.1016/j.addr.2016.10.005

No abstract available

Keywords: anti-diabetic peptides; intestinal permeation enhancers; nanocarriers; nanomedicines; nanotoxicology; oral peptide delivery.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Drug Delivery Systems
Macromolecular Substances
Peptides*
Pharmaceutical Preparations*

Substances

Macromolecular Substances
Peptides
Pharmaceutical Preparations